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Background 
Coconut fat has gained a lot of attention for its claimed beneficial effects concerning health. Its fat 
content is made up of approximately 90% saturated fatty acids. The intake of saturated fats affects 
blood cholesterol levels. Cholesterol can be measured through total cholesterol (TC), Low Density 
Lipoprotein (LDL), High Density Lipoprotein (HDL), Very Low Density Lipoprotein (VLDL) 
and LDL/HDL ratio. Research has been done on single fatty acids from coconut fat and positive 
results regarding health have been reached. However it is important to elucidate that conclusions 
based on studies made on single fatty acids may differ from coconut fat as a whole.  
Objective 
The aim of this systematic review was to investigate how a diet rich in coconut fat would affect 
blood cholesterol levels when it came to TC, LDL, HDL and the LDL/HDL-ratio.  
Search strategy 
The databases PubMed and Scopus were used in the literary search process for relevant articles. 
Search words of importance for the systematic reviews’ research question were applied.  
Selection criteria 
RCT, CCT and cohort studies from 1990 to present, both investigating coconut fat vs. other fats as 
well as coconut fat vs. placebo were considered. Studies including pregnant women, participants 
using drugs that influenced blood lipid metabolism or studies on single fatty acids were excluded. 
Data collection and analysis 
Appropriate materials were selected and three final studies were chosen, two RCT and one CCT. 
The study quality and the strength of evidence of the endpoints were based upon the validation 
template Granskningsmall för randomiserade studier, Granskningsmall för observationsstudier 
och icke-randomiserade kontrollerade studier and Sammanfattande Evidensformulär.  
Main results 
The test diets rich in coconut fat (SFA diets) led to significantly higher TC and LDL levels 
compared to diets rich in HUFA (safflower oil, soya-bean oil or a HUFA mix). Only one study 
showed significantly higher HDL levels in all its subjects after a coconut fat diet. TC and LDL 
were significantly higher on a butter diet compared to a coconut fat diet (SFA versus SFA). The 
LDL/HDL ratio was lower after the HUFA mix diet compared to the SFA diets.  
Conclusions 
Coconut fat as the main fat in the diet significantly increases TC and LDL levels, which is today 
not considered beneficial regarding blood cholesterol in relation to health. The outcomes on HDL 
levels however differ between the studies. The LDL/HDL ratio is higher when comparing coconut 
fat diets with a HUFA diet. The strength of evidence regarding coconut fat’s effect on TC, LDL 
and HDL is measured mediate-high (+++) and for LDL/HDL ratio low (++). 
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Bakgrund  
Kokosfett har fått mycket uppmärksamhet för sina påstådda positiva hälsoeffekter. 
Fettsammansättningen i kokos består av cirka 90 % mättade fettsyror. Mättat fett påverkar 
kolesterolhalten i blodet. Kolesterol kan mätas genom totalkolesterol (TC), Low Density 
Lipoprotein (LDL), High Density Lipoprotein (HDL), Very Low Density Lipoprotein (VLDL) 
och kvoten mellan LDL och HDL. Forskning har gjorts på enskilda fettsyror från kokosfett och 
resultat på gynnsamma hälsoeffekter har visats. Det är dock viktigt att belysa att slutsatser 
baserade på studier gjorda på enskilda fettsyror kan skilja sig från kokosfett i helhet.  
Syfte 
Syftet med denna översiktsartikel var att undersöka hur en kost rik på kokosfett påverkar 
kolesterolhalten i blodet gällande TC, LDL, HDL och LDL/HDL-kvoten. 
Sökväg 
Databaserna PubMed och Scopus användes i litteratursökningsprocessen för att få fram lämpliga 
artiklar. Sökord av betydelse för översiktsartikelns frågeställning användes.  
Urvalskriterier 
RCT, CCT och kohortstudier från 1990 och framåt som undersökte kokosfett vs. andra fetter eller 
kokosfett vs. placebo inkluderades. Studier med gravida kvinnor samt deltagare som använde 
läkemedel som påverkade blodfettsmetabolismen eller studier på enskilda fettsyror exkluderades. 
Datainsamling och analys 
Ett urval av adekvat material gjordes och tre studier valdes, två RCT och en CCT. Studiekvalitén 
samt graden av effektmåttens evidensstyrka bedömdes utifrån Granskningsmall för 
randomiserade studier, Granskningsmall för observationsstudier och icke-randomiserade 
kontrollerade studier och Sammanfattande Evidensformulär. 
Resultat 
Testdieterna rika på kokosfett (SFA-kost) gav signifikant högre TC- och LDL-nivåer jämfört med 
testdieterna rika på HUFA (tistelolja, sojabönsolja eller HUFA-mix). Endast en studie visade på 
signifikant högre nivåer av HDL i gruppen som helhet efter en kost med kokosfett. TC och LDL 
var signifikant högre med smör som testfett jämfört med kokosfett (SFA vs. SFA). LDL/HDL-
kvoten var lägre efter en HUFA-diet jämfört med SFA-dieterna. 
Slutsats 
Kokosfett som det dominerande fettet i kosten ger en signifikant ökning av TC och LDL, något 
som idag anses vara ofördelaktigt gällande blodkolesterolhalten relaterat till hälsan. Effekten på 
HDL skiljer sig åt mellan studierna. LDL/HDL-kvoten är högre när man jämför en kost rik på 
kokosfett med en kost rik på HUFA. Evidensstyrkan för kokosfettets påverkan på TC, LDL och 
HDL bedöms vara måttlig (+++) och för LDL/HDL-kvoten låg (++).   
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Abbreviations and explanations 
 
ANOVA - Analysis of Variance 
CCT  - Clinical Controlled Trial  
CVD  - Cardiovascular Disease 
E% - Energy Percentage  
HDL - High Density Lipoprotein 
HSFA - High Saturated Fatty Acids 
HUFA - High Unsaturated Fatty Acids 
LDL - Low Density Lipoprotein 
LSFA - Low Saturated Fatty Acids 
MCT - Medium-Chain Triglyceride 
NNR  - Nordic Nutrition Recommendations 
PUFA - Poly Unsaturated Fatty Acids 
RCT  - Randomized Controlled Trial 
SFA - Saturated Fatty Acids 
TC  - Total Cholesterol 
VCO - Virgin Coconut Oil/Fat 
VLDL - Very Low Density Lipoprotein 
WC  - Waist Circumference  
 
Analysis of Variance (ANOVA) - Provides a statistical test showing if the means of more than  
    two groups are equal or not 
Bias  - Method error 
Bonferroni   - Statistical analysis method used to face the issue of multiple  
    comparisons 
Diet record  - Retrospective food journal, often used as a dietary  
    assessment method 
Dyslipidemia - A state where the blood lipid levels are too high or too low  
Latin-square design - An experimental design implied to control the 
    randomization in trials 
P-value  - Indicates the probability in which a certain outcome would  
    have occurred by chance 
Polyphenolic  - A type of antioxidant 
Primary prevention - A measure to prevent the onset of diseases 
Run-in period - An amount of time set to give all participants the same base  
    before the trial starts 
Secondary prevention - A measure to stop or slow down an already diagnosed 
    condition or risk factors as well as preventing re-injury 
Student’s t-test - A statistical test used to examine whether there is a  
    difference between two normal populations where the  
    standard deviation is not given 
Virgin Coconut Oil - Extracted directly from coconut under controlled temp 
Washout period - A period in between two intervention episodes with the aim  
    to prevent the previous intervention to affect the next one
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Introduction 
 
 
Background 
 
Coconut has been consumed for a long time, especially within Asian cuisine. The supply and 
interest in coconut consumption has increased during the last few years. It is promoted as a dietary 
supplement said to optimize health(1). The edible part of the coconut consists of the white flesh 
(copra) and coconut milk (also called coconut water). It is from the flesh coconut fat is 
extracted(2). 
 
Coconut fat consists mainly of saturated fatty acids, this being about 90%. The major fatty acids 
present in coconut fat are lauric acid (12:0) with 46%, myristic acid (14:0) with 17% and palmitic 
acid (16:0) with 9%. Only 10% are unsaturated fatty acids in contrast to olive oil for example, 
which consists of 87% unsaturated fatty acids. Even when comparing coconut fat with other foods 
high in saturated fats, for example butter, coconut fat has a higher proportion of saturated fatty 
acids (90%). than butters 66%. However they differ in the percental distribution of their diverse 
saturated fatty acids(3). 
 
According to the Nordic Nutrition Recommendations (NNR), the intake of saturated fatty acids 
including trans fats should be limited to a maximum of 10 E%. It has been found that a reduction 
in consumption of saturated fatty acids can lead to lowered levels of blood cholesterol(4). 
 
In the diet, the intake of saturated fats is among the factors that affect the cholesterol levels the 
most. Cholesterol in the blood can be measured in TC, LDL, HDL, VLDL and the ratio of LDL 
and HDL(5, 6). TC covers the total values of LDL, HDL and VLDL. LDL is usually referred to as 
the "bad" cholesterol because of the fact that high levels of it can accumulate in the blood vessel 
walls and form plaque, which in its turn can lead to a narrowing of the blood vessels. A major 
consequence of this process is that the speed of the blood flow is reduced, resulting in an increased 
risk of CVD. HDL is known as the "good" cholesterol because of its association with a lower risk 
of cardiovascular disease and its anti-oxidative properties. The function of HDL is to pick up 
excess cholesterol from the body tissues back to the liver to be utilized(6, 7). Therefore the 
recommendations are set for the population to have high HDL levels and low LDL levels. When 
assessing the risk of “good” and “bad” cholesterol, a valid method to use is the ratio between 
LDL/HDL(5). The aim is to have as low ratio as possible, as this presents a lower level of LDL 
and a higher level of HDL(6). 
 
The primary prevention target values for CVD are for TC < 5.0 mmol/L, LDL < 3.0 mmol/L, 
HDL > 1.0 mmol/L (for men) and HDL > 1.3 mmol/L (for women) according to what is currently 
practiced within Swedish healthcare. These values also apply when taking into account other risk 
factors and the patient's overall health. For secondary prevention and high-risk groups the target 
values are for TC < 4.5 mmol/L and LDL < 2.5 mmol/L(5). With an altered diet, a change in 
blood cholesterol can be seen already after about two weeks. A maximal effect is reached after 
about four weeks(8). 
 
Lauric acid, myristic acid and palmitic acid are among the saturated fats that raise LDL cholesterol 
and are proven to be major risk factors in the development of cardiovascular diseases. Myristic 
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acid and palmitic acid have also shown to raise HDL levels in the blood. As brought up 
previously, these three fatty acids are present in large amounts in coconut fat(3, 4, 7). 
 
There is a broad range of current research, discussions and publications about the various health 
aspects of coconut, including its cholesterol-lowering effect. A study examining the effects of 
virgin coconut oil (VCO) on lipid profile in healthy males concluded that an intake of VCO 
caused a significant decrease in HDL levels(1). Another study was made on women between 20 to 
40 years old with abdominal obesity (WC > 88 cm) investigating the effects of dietary fat on 
coconut profiles regarding weight, WC and blood lipid levels. This study showed that coconut fat 
was not involved in the causation of dyslipidemia and contributed to a reduction of abdominal 
obesity in the study population(9). Furthermore, tests on rats have shown beneficial effects from 
an intake of VCO. A study on rats from 2003 comparing VCO and “regular” coconut fat (copra), 
ie refined oil, presented this. The results showed lowered TC and LDL blood cholesterol levels 
and increased HDL levels with VCO. This was explained by the biologically active polyphenolic 
components present in VCO(10). 
 
The main fatty acids in coconut fat belong to the group of fatty acids called MCT, i.e. medium-
chain fatty acids. Over 50% of the fatty acids in coconut fat are MCT fats. These are absorbed 
intact from the small intestine and do not undergo degradation and reesterification processes. They 
are directly used in the body to produce energy. In a study investigating possible health effects of 
coconut constituents, it was claimed that MCT fats were, unlike other fatty acids, not stored in fat 
deposits and therefore of great interest for weight reducing diets. Many studies investigate 
separate MCT fatty acids and not the complete composition of coconut fat. It is important to 
highlight the fact that a single fatty acid cannot be compared to coconut fat as a whole since it 
consists of a various range of different fatty acids being short, medium and long chained(11). 
 
Problem formulation 
 
The current recommendations on fat intake, according to NNR, are to keep intakes of saturated 
fats including trans fats below 10 E%. It has been found that a reduction of the consumption of 
saturated fatty acids leads to a reduction of blood cholesterol. Coconut fat is composed mainly of 
saturated fatty acids (90%). Despite the high content of saturated fats, it is alleged that coconut fat 
has beneficial effects on blood cholesterol, on the basis of a different fatty acid composition 
compared with other foods rich in saturated fats, such as butter. The parted views have led to an 
interest of further investigation surrounding coconut fats effects on blood cholesterol in humans.  
 
Objective 
 
The aim of this systematic review is to investigate how an intake of coconut fat would affect blood 
cholesterol levels when it comes to TC, LDL, HDL and the LDL/HDL-ratio.  
 
Research question 
 
Does an oral intake of coconut fat have beneficial effects regarding blood cholesterol levels (TC, 
LDL, HDL and the LDL/HDL-ratio) in healthy adults? 
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Method 
 
 
Inclusion- and exclusion criteria 
  
The following inclusion search criteria for this systematic review was to be on human studies with 
a healthy population between 18 – 79 years old. Studies based on coconut fat versus other fats as 
well as coconut fat versus placebo were included in the inclusion criteria. The study designs RCT, 
CCT and cohort published from 1990 and on were considered. There were no restrictions on the 
sum of participants, study duration or amount of coconut fat consumed during the study. The 
research substance was to be exclusively coconut fat and not single fatty acids extracted from 
coconut fat. Studies involving participants using drugs known to influence blood lipid metabolism 
were excluded, as well as studies with pregnant women.  
  
 
Data collection method 
 
The literary search was done within the databases PubMed and Scopus using a range of search 
words to gather the most relevant information. Search functions AND and/or OR were used to 
collect appropriate articles. Keywords mentioned in found articles were of great help when it came 
to further literature searches. Databases, search words, limitations, matches found and articles 
chosen are presented in Table 1.  
 
 
Data processing 
 
During the literary reviews search in the two databases, the study titles were looked upon. In cases 
where the titles were considered of relevance for the research question or where the aim of the 
study was not apprehensive enough by only reading the title, the abstract would also be read. 
Abstracts not being under the chosen inclusion criteria were left out. The first elimination round 
left behind 19 studies where the abstracts of these were read once again. They were thoroughly 
analysed in order to determine whether they definitely fell under the inclusion criteria or not. The 
19 studies mentioned above can be found in Table 1. A total of eleven studies remained after the 
detailed abstract analysis. All of these were read in full text. Out of eleven articles read in full text, 
eight were excluded because they were judged to have a risk of bias. Examples of bias included 
reported data which relied on participants subjective answers, that a single fatty acids derived from 
coconut fat was analysed instead of coconut fat as a whole, the overall food intake was not 
controlled, there was no control group, no measured description of the endpoints, no washout 
periods between the test oils or a simultaneous start of regular physical activity parallel to the 
intervention. A final of three studies, two RCT and one CCT, remained. However, some of the 
excluded articles would be used within the introduction and discussion section. 
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Table 1. Data collection method 
Database Date Search word Limitations Matches 
found 
Chosen 
articles 
Authors, Year 
PubMed 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”cholesterol” 
Human, 
Year 1990 to present 
46 12 Feranil et al. 2011**(12) 
Cox et al. 1995(13) 
Cox et al. 1998**(14) 
Mendis et al.1990(15) 
Kumar et al. 1997**(16) 
Assuncao et al. 2009**(9) 
Karupaiah et al. 2011*(17) 
Müller et al. 2003(18) 
Ng K.W. et al. 1992**(19) 
Schwab et al. 1995**(20) 
Mendis et al. 2001*(21) 
Lu et al. 1997*(22) 
PubMed 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”blood lipids” 
Human, 
Year 1990 to present 
2 0  
PubMed 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”LDL” 
Human, 
Year 1990 to present 
30 5 [5]  
PubMed 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”HDL” 
Human, 
Year 1990 to present 
26 6 [6]  
PubMed 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”health” 
Human, 
Year 1990 to present 
37 
 
4 [1] Sircar et al. 1998*(23) 
Hebert et al. 1990*(24) 
Amarasiri et al. 2006*(11) 
Scopus 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”cholesterol” 
Human, 
Year 1990 to present 
52 16 [13] Sabitha et al. 2009**(25) 
Woo et al. 1998*(26) 
Paz et al. 2010**(1) 
Scopus 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”blood lipids” 
Human, 
Year 1990 to present 
4 0  
Scopus 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”LDL” 
Human, 
Year 1990 to present 
27 10 [10]  
Scopus 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”HDL” 
Human, 
Year 1990 to present 
23 10 [10]  
Scopus 2013-05-01 
 
”coconut oil” OR ”coconut fat” 
AND ”health” 
Human, 
Year 1990 to present 
51 7 [6] Lipoeto et al. 2001*(27) 
 
       
 [ ] = duplicates   * = excluded after a closer abstract review   ** = excluded after a closer full text review
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Relevance and quality review 
 
The validation templates Granskningsmall för randomiserade studier and Granskningsmall för 
observationsstudier och icke-randomiserade kontrollerade studier designed by the Swedish 
Council on Health Technology Assessment (SBU) were used in the quality controls of the three 
selected studies (see appendix 1 and 2). The four selected endpoints were TC, LDL, HDL and 
LDL/HDL ratio. The strength of evidence ranged from one (+) to four (++++) plus and was 
decided using the template Sammanfattande Evidensformulär developed by Gothenburg 
University (see appendix 3).  
 
Results 
 
The three studies included in the systematic review with the aim of investigating the effects of 
coconut fat intake on blood cholesterol levels are described initially under results. Table 2 
briefly concludes all the selected studies. The results section is finalized with a study quality 
summary (Table 3) as well as a presentation of the evidence strength levels (Table 4). As the 
included studies intervention length ranged from three to eight weeks it should be highlighted 
that only short-term effects on blood cholesterol levels are portrayed here. 
 
Study 1: Cox et al. 1995 (13)  
Effects of coconut oil, butter, and safflower oil on lipids and lipoproteins in persons with 
moderately elevated cholesterol levels 
 
 
Method 
 
A total of 28 subjects, 13 men and 15 women, 29 to 67 years old were included in the study. 
Body weight was recorded at baseline and at week 4 and 6 in each diet period. Cholesterol 
levels of the participants ranged from 5.5 to 9.7 mmol/L. The study duration was held for a 
total of six months, which started with a six-week run-in period where a 5-day food record was 
to be filled in by the subjects in order to collect information about the participants’ food and 
nutrient intakes.  
 
The study was built up by three separate dietary fat intervention periods, each of them being six 
weeks. The participants were randomized into one of three dietary periods based on the 
randomizing design Latin-square. This design can be explained as a run-in period with a 
normal diet during six weeks followed by a randomized order of the test fats being either: 
1. Coconut fat diet - Butter fat diet - Safflower oil diet 
2. Butter fat diet - Safflower oil diet - Coconut fat diet 
3. Safflower oil diet - Coconut fat diet - Butter fat diet 
 
During the run-in period, participants were asked to report their everyday dietary intake and 
from this information their individual energy intake was calculated. These calculated personal 
energy intake levels were used in all three intervention periods. The fats provided from the 
three different diets were approximately 36 E%. In the Coconut fat diet, 46% of the fat content 
was from coconut. The same ratio of butter was given in the Butter fat diet. In the Safflower oil 
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diet, 29% of the fat content was from safflower oil. A 5-day diet record measured dietary 
compliance in each intervention period. Participants were regularly checked upon through 
interviews and telephone calls. A continuous habitual physical activity pattern and further 
lifestyle features was encouraged throughout the study.  
 
Kits and calibrators from Boehringer-Manheim and Roche Diagnostics were used to assess TC, 
LDL and HDL from the participants’ blood samples.  Blood cholesterol was measured at week 
4 and 6 in each dietary period. The results were statistically analyzed using ANOVA and paired 
Student’s t-test.  
 
 
Results 
 
TC and LDL levels were the highest on the butter fat diet, intermediate on the coconut fat diet 
and lowest on the safflower oil diet, all of these being statistically significant. HDL levels did 
not vary significantly when it came to the group as a whole. Looking only at the women’s 
results HDL levels were significantly higher on the butter and coconut fat periods compared to 
the safflower oil diet (see appendix 4). The amount of SFA and PUFA were equivalent in the 
butter diet and in the coconut fat diet. Total energy intake and percental energy proportions 
remained constant during the study. Regarding the mean body weight of the subjects, this 
remained unchanged throughout the study(13). 
 
 
Study 2: Mendis et al. 1990 (15) 
The effect of daily consumption of coconut fat and soya-bean fat on plasma lipids and 
lipoproteins of young normolipidaemic men 
 
 
Method 
 
A total of 25 subjects, all men, aged 20 – 26 years were included in the study. All subjects were 
within the range of normal body weight. The study consisted of two intervention periods, each 
being eight weeks. There was a washout period of three weeks between the two diet episodes. 
The aim of this washout period was to minimize the impact of the previous test fat on the next 
intervention episode. All participants started out with eating the soya-bean diet followed by a 
washout period and subsequently the coconut fat diet. 
 
The study was built up by two diets based on different fats, coconut fat respectively soya-bean 
fat, served in their meals as the main source of fat for lunch and supper. Both dietary 
interventions were of same fat energy distribution. The percental amount of the different 
intervention fats was the same, this being around 70%. Also, the carbohydrate intake and 
composition were of equal amount in the two diets. Alcohol consumption was not allowed 
during the study. Interviews were conducted with the subjects to keep track of their compliance 
levels.  
 
Blood cholesterol was measured in the beginning and at the end of each intervention period. 
During the two last weeks of the intervention period, two consecutive blood samples were 
taken to determine the level of TC and calculate the definite lipid change. Statistical analyses 
were made using paired Student’s t-test.  
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Results  
 
There were no significant differences when it came to the mean values of TC, LDL and HDL at 
the end of the coconut fat diet period compared to the baseline values. Mean results of TC after 
the coconut fat diet differed significantly from the soya-bean fat diet, as the TC levels were 
lower during the soya-bean fat diet (see appendix 4). Both HDL and LDL were lowered after 
the soya-bean intervention compared to baseline. It was judged to be a good compliance among 
the participants based on their interview answers. Their body weight did not differ considerably 
during the study(15). 
 
 
Study 3: Müller et al. 2003 (18) 
The serum LDL/HDL cholesterol ratio is influenced more favourably by exchanging saturated 
with unsaturated fat than by reducing saturated fat in the diet of women 
 
 
Method 
 
A total of 31 subjects, all women, aged 20 – 40 years participated and 25 of them completed the 
study. BMI of the participants ranged from 21.3 to 27.7 kg/m2. Their body weight was checked 
twice a week.  
 
The participants were randomized into one of three groups based on the randomizing design 
Latin-square. This design compromises a randomized order of the test fats being either: 
1. High SFA – Low SFA –HUFA 
2. Low SFA –HUFA – High SFA 
3. HUFA – High SFA – Low SFA 
This design also determined in which sequence the test fats would be received. Period 1 and 2 
were 22 days each and period 3 was 20 days. Between two different test periods, a washout 
period of one week took place where they would go back to their normal eating habits.  
 
The study compared the effects on blood cholesterol of a low amount of fat diet based on SFA 
(the main source being coconut fat, 80%), a high amount of fat diet based on SFA (the main 
source being coconut fat, 80%) and a high amount of fat diet based on HUFA (the sources 
being a mixture of sunflower oil, rapeseed oil, coconut oil and palm oil). Equal proportions of 
fat were presented in the High SFA and HUFA diets (42 E%). The Low SFA diet was based on 
22 E% fat. The High SFA and the Low SFA diets had the same combination of fats. All 
weekday meals were prepared under supervised means. No foods other than the test foods were 
to be consumed during the intervention periods and neither were alcoholic beverages. 
Continuous habitual physical activity patterns as well as other lifestyle features were 
encouraged throughout the study period.  
 
Blood cholesterol of the subjects was measured at baseline and at the end of each intervention 
period. Results were statistically analyzed using ANOVA and the Bonferroni method, the later 
one for pair wise comparisons between the three diets. A confidence limit of 95% was used for 
statistical assessment. 
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Results 
 
The results were the following: 
• TC was higher after the High SFA diet than after the Low SFA diet. 
• TC and LDL after the HUFA diet were significantly lower compared to the two SFA 
diets. 
• LDL showed a slight difference when comparing the High with the Low SFA diet.  
• HDL was after the High SFA diet significantly higher compared to the Low SFA diet or 
the HUFA diet.  
• The LDL/HDL ratio was significantly higher after the Low SFA diet compared to the 
High SFA diet. The ratio was also higher after both SFA diets than after the HUFA diet 
(see appendix 4).  
 
There was a general high level of compliance. Body weights of the participants at the end of the 
diet periods had not differed significantly (18).  
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Final results  
 
Table 2. Final results of studies chosen after intervention 
Author, Year Study 
design 
Study 
population 
Intervention TC 
(mmol/L) 
LDL 
(mmol/L) 
HDL 
(mmol/L) 
LDL/HDL ratio 
(mmol/L) 
Study 
quality 
Cox et al. 
1995(13) 
RCT n: 28 
f: 15 
m: 13 
 
Test fats 
• CF 6 w 
• BF 6 w 
• SO 6 w 
 
 
In a randomized order 
Run-in period 6 w 
 
Test fats: 
29-46% of fat E% 
 
• CF: 6.4 
• BF: 6.8  
• SO: 6.1  
All values: (p<0.001) 
 
 
CF, BF, SO in order: 
f:   6.3, 6.7, 5.9 
All values (p<0.01) 
 
 
m: 6.6, 7.0, 6.2 
All values (p<0.01) 
• CF: 4.2  
• BF: 4.5  
• SO: 3.9  
BF v. CF or SO (p<0.001) 
CF v. SO  (p<0.004) 
 
CF, BF, SO in order: 
f: 4.0, 4.4, 3.8 
BF v. CF or SO (p<0.005) 
CF v. SO (nsd) 
 
m: 4.4, 4.7, 4.0 
SO v. BF or CF (p<0.01) 
BF v. CF (nsd) 
• CF: 1.5  
• BF: 1.4  
• SO: 1.4  
All values: (nsd) 
 
 
CF, BF, SO in order: 
f: 1.8, 17, 1.6 
SO v. BF or CF (p<0.02) 
CF v. BF (nsd) 
 
m: 1.2, 1.2, 1.2 
(nsd) 
 
 High-
mediate 
high 
Mendis et al. 
1990(15) 
CCT n: 25 
m: 25 
Test fats 
• SbF 8 w 
• CF 8 w 
Washout period 3 w 
Test fats: 70% of fat E% 
B: 4.64  
• SbF: 3.68  
(p<0.001 from B) 
• CF: 4.61  
(p<0.001 to SbF) 
B: 2.95  
• SbF: 2.27  
(p<0.001 from B) 
• CF: 2.84  
(nsd) 
B: 1.10  
• SbF: 0.94  
(p<0.05 from B) 
• CF: 1.14  
(nsd) 
 High 
Müller et al. 
2003(18) 
RCT n: 25 
f: 25 
Test fats 
• LSFA 20-22 d 
• HSFA 20-22 d 
• HUFA 20-22 d 
 
In a randomized order 
Washout period 1 w 
LSFA 22 E% fat* 
HSFA 42 E% fat* 
HUFA 42 E% fat** 
B: 4.95  
• LSFA: 5.13  
• HSFA: 5.38 
• HUFA: 4.41  
 
HUFA v. HSFA or 
LSFA (p<0.01)  
B: 2.99  
• LSFA: 3.12  
• HSFA: 3.20 
• HUFA: 2.52  
 
HUFA v. HSFA or LSFA 
(p<0.01) 
B: 1.42  
• LSFA: 1.44  
• HSFA: 1.69 
• HUFA: 1.44  
 
HSFA v. LSFA or HUFA 
(p<0.01) 
B: 2.31  
• LSFA: 2.43  
• HSFA: 2.10 
• HUFA: 1.92  
 
LSFA v. HSFA or 
HUFA (p<0.01) 
High-
mediate 
high 
         
*: main source coconut fat (80%) 
**: a mix of sunflower, rapeseed, 
coconut and palm oil 
       
       n: subjects  
       m: male  
 f: female  
      
 d: days  
 w: weeks  
 nsd: no significant difference 
 (p>0.05) 
B: Baseline (mean) 
CF: Coconut fat (mean)  
BF: Butter fat (mean)  
 
SO: Safflower oil (mean)  
SbF: Soya-bean fat (mean)   
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Study quality judgement 
 
The studies chosen were judged to have a low risk of bias. A valid randomization design was 
used in two studies, all three studies were of cross-over design and the study duration was of 
appropriate time, i.e. more than two weeks(8). Every participant received the same treatment, 
there was a good general compliance, endpoints had a low risk of bias, valid methods of 
endpoint measurements and a low risk for conflicts of interest. All the aspects mentioned above 
motivate the fact that the studies were quality judged between high to mediate high. All three 
studies lacked information about side effects as well as blinding.  
 
Table 3. Study quality 
Author, 
Year 
Study 
design 
Study 
quality 
Comments 
Cox et al. 
1995 
RCT High-
mediate 
high 
There was no information about whether the participants were blinded or 
not. In addition to this, meals were prepared by the subjects themselves at 
home, which could contribute to a higher risk of bias. There was no washout 
period between the intervention diets. From this information it was 
concluded that the study was of high to mediate high quality.  
Mendis et al. 
1990 
CCT High Even though the study did not mention if the participants were blinded or 
not, it did not affect the judgement of the study’s overall quality. Mainly due 
to the fact that the meals given were ready-made.  
Müller et al. 
2003 
RCT High-
mediate 
high 
Study quality was measured as high to mediate high because no information 
was given about the impact of the dropouts on the final results. Neither was 
any information about blinding presented.  
    
 
Evidence grading  
 
The four endpoints investigated are presented below. Out of these four, all three studies looked 
into TC, LDL and HDL whilst only one investigated the LDL/HDL ratio. Since the studies 
lacked information on blinding, internal validity was judged to have some limitations. When it 
came to correspondence, there was some heterogeneity because of various intervention 
durations in between the examined studies. All studies involved had a low amount of 
participants and the external validity was judged to uncertainty. The LDL/HDL ratio was only 
mentioned in one study and therefore judged as having ‘some problems’ when it came to vague 
basic data. 
 
Table 4. Strength of evidence 
Endpoints  
TC LDL HDL LDL/HDL ratio 
Number of studies 3 3 3 1 
Study design  
– internal validity 
Some  
limitations 
Some  
limitations 
Some  
limitations 
Some 
limitations 
Correspondence Some  
heterogeneity 
Some  
heterogeneity 
Some  
heterogeneity 
Some  
heterogeneity 
Study population  
– external validity 
Uncertainty Uncertainty Uncertainty Uncertainty 
Vague basic data No problems No problems No problems Some problems 
Strength of evidence Mediate-high (+++) Mediate-high (+++) Mediate-high (+++) Low (++) 
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Discussion 
 
 
Main findings 
 
After investigating the three studies, different effects on blood cholesterol from an oral intake 
of coconut fat have been shown. Beneficial effects on blood cholesterol can be defined, 
according to the practiced healthcare guidelines, as lowering levels of TC and LDL, increasing 
levels of HDL and having a low LDL/HDL ratio(5). Seen in this systematic review, a diet rich 
in coconut fat led to significantly higher TC and LDL levels compared to a diet rich in HUFA 
(safflower oil, soya-bean oil or a HUFA mix). Only one study showed significantly higher 
HDL levels in all its subjects after a coconut fat diet compared to a HUFA diet.   
 
Comparing coconut fat with safflower oil or soya-bean oil (the diet being mainly saturated fat 
respectively unsaturated fats) TC and LDL levels were lower after the soya-bean and safflower 
interventions(13, 15). Comparing coconut fat with butter (their main source consisting of 
saturated fats), it was seen that TC and LDL levels were significantly higher on the diet based 
on butter than on the one based on coconut fat(13). TC and LDL were significantly higher in 
the HSFA and LSFA diets (based on coconut fat) compared to the HUFA diet. However, HDL 
was significantly higher after the HSFA diet compared to the LSFA diet or the HUFA diet(18). 
Apart from Müllers study, the overall HDL cholesterol levels, in the remaining two studies, did 
not differ significantly between the different intervention diets in the group as a whole. On the 
other hand, in one study, the women’s HDL levels were significantly higher on the butter and 
coconut fat diets compared to the safflower oil diet(13). The LDL/HDL ratio was in total 
lowered after the HUFA diet compared to both SFA diets but only significantly lower after the 
LFSA diet. The study measuring the ratio concluded that the amount of fat in the diet was not 
of main importance, but the composition of the fat quality being crucial. Since this study only 
involved women, the results can only be based on women as well(18). 
 
 
Coconut fat – not single fatty acids 
 
There is a possibility that different conclusions are reached when investigating the impact of 
single fatty acids, such as MCT, compared to a complete fat source, as for example in this 
paper, being coconut fat. The possible differences could be since coconut fat is known to have a 
high amount of MCT fats, but also has other fatty acids and components that can affect the 
outcome. Studies that have examined MCT fats beneficial effects on health in general, positive 
effects have been demonstrated in, for example, weight loss. These studies results claimed that 
an intake of coconut fat has a positive impact on weight and health(28-30). The question is; can 
one conclude that coconut fat has beneficial effects when only individual fatty acids have been 
investigated? 
 
 
Coconut fat – Cholesterol – Cardiovascular disease 
 
In this systematic review the relationship between the consumption of coconut fat and blood 
cholesterol levels, and not the relationship between coconut fat and CVD, has been examined. 
It has not been investigated in what way an intake of coconut fat may increase the risk of CVD, 
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but only the extent to which it affects cholesterol levels in the blood. To be able to express how 
coconut fat would affect the incidence of CVD, research has to be divided into two steps: the 
first being coconut fats effect on blood cholesterol and the second being cholesterols effect on 
CVD. Regarding the second step, a comprehensive international study, named the 
INTERHEART study, concluded dyslipidemia as a major risk factor for CVD(31). 
 
 
Study design – dietary composition 
 
In the different intervention diets, the percentages of test fats of the total fat intake differ. 
Levels were 46% in study 1 (Cox et al.), 70% in study 2 (Mendis et al.) and 80% in study 3 
(Müller et al.). Consuming the test fat as half of the daily fat intake compared to eating three 
quarters of the daily fat intake as test fat may possibly play a role in how big the impact on the 
cholesterol levels will be. The difference in coconut fat percentage in the diet can thus make a 
difference in the final results. Common in all three studies is that the participants consume 
more saturated fat than NNRs recommended level. Despite the percental differences of 
consumed test fat, the results of the studies all follow the same pattern in blood cholesterol 
measures. 
 
In study 1 (Cox et al.), the participants were moderately hypercholesterolemic at baseline. In 
study 2 (Mendis et al.) and study 3 (Müller et al.) their baseline cholesterol levels were within 
recommended levels. In this systematic review, the focus has been comparing the effects on 
blood cholesterol between coconut fat with either another SFA fat or a HUFA fat as the main 
fat in the diet. Less focus has been put on comparing the cholesterol levels from baseline. This 
due to the fact that it is assumed that some kind of fat will most probably be included in a 
person’s daily diet and therefore of broader interest to examine the possible contrasting effects 
of the different kinds of fat rather than to baseline values. To be noted is that despite slight 
differences in baseline values, the results in blood cholesterol levels all follow similar patterns. 
 
It should be mentioned that conclusions drawn in this systematic review are presenting values, 
which are based on having coconut fat as the main fat in the diet and not as a food that is rarely 
eaten. Therefore no statements are pronounced on the amount of consumed coconut fat needed 
for a potential impact on blood cholesterol levels. 
 
 
Study design – length, gender and species  
 
The results are based on short-term interventions (three to eight weeks) and can therefore only 
speak for short-term effects on blood cholesterol. To see an alternation in the blood cholesterol 
levels from a changed diet, a minimum of two weeks is needed. A maximal effect is reached 
after about four weeks(8). The studies investigated in this systematic review were spread from 
three to eight weeks. Due to these facts, the intervention periods in the included studies were of 
adequate study duration and are therefore judged to show reliable results. Would the study 
period have stretched over a very long time, for example several years, other factors such as 
illnesses occurred within the study period could have had an impact on the outcomes. Opposite 
to this, an intervention period being very short, i.e. less than two weeks, the time would not 
have been sufficient enough to be able to see any differences in blood cholesterol levels. 
 
As seen in Table 2, the study where women and men participated under the same 
circumstances, the women’s cholesterol values tended to result in lower levels in TC and LDL 
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and higher in HDL compared to the men. The study’s results show that the women had higher 
HDL levels compared to the men regardless of which fat was being tested. These results go 
hand in hand with the already existing primary prevention target values for CVD which present 
higher values on HDL for women compared to men(5).  
 
In the present systematic review, animal studies have been excluded as they represent other 
species than humans. To be able to conclude results on coconut fat’s effects on humans, it was 
decided that only studies based on people would be used. Additionally, studies including 
pregnant women and individuals taking blood lipid lowering medication were excluded. This 
was because pregnant women can have changed metabolic features during their pregnancy, 
which can portray a risk of possible bias. The same hypothesis applied for studies involving 
participants using drugs known to influence blood lipid metabolism.   
 
 
Study design – strengths and weaknesses 
 
Due to various aspects of power in the chosen studies, it can be concluded that the overall 
judgement of the study quality is high. Specific strengths include randomization designs(13, 
18), run-in period(13), washout periods(15, 18), regular checkups, equal E% proportions of fat 
and prepared meals(15, 18). The randomization design helps to increase the validity and 
minimize the risk of bias in the studies. Run-in periods alleviate all the participants in these 
studies to start from more similar baseline conditions. With a washout period, the risk of the 
previous intervention intervening with the following one is reduced. Regular checkups in 
different forms such as telephone calls, diet records and interviews during an intervention 
period will provide more reliable results than for example if no check up was to be done. In two 
of the selected studies, the meals were prepared and served under controlled conditions, which 
gives more credibility to results found(15, 18). In studies not controlling the total energy intake 
or E% proportions the risk of self-handeledy altering the results are higher and were therefore 
excluded(1).  
 
Weaknesses in the selected studies could be that all three studies lacked information about side 
effects as well as blinding. No side effects were mentioned which can be interpreted as if on 
one hand there were no side effects, and on the other as if they were not exposed. The 
importance of blinding should not be neglected as it provides credibility for results found. For 
example, if a participant is aware of which test fat he or she is going to eat and wants this to 
show a certain result, hypothetically speaking, the participant could unreported eat foods that 
are known to have a certain effect on cholesterol levels. Under the same reasoning, a 
participant could eat lipid-lowering drugs during an intervention period to affect their 
cholesterol, without reporting the usage of drugs. All the facts and examples mentioned above 
could contribute to possible risks of bias.  
 
Some of the studies excluded had a high risk of bias due to, among others, starting parallel 
sequences of physical activity during their intervention period, instructions to increase the 
intake of fruits and vegetables and reduce simple carbohydrates and animal fat. Such 
alternations in an individual’s daily life can effect blood cholesterol levels and contribute to 
biased results. Apart from these aspects, studies with self reported data and retrospective 
materials gave subjective results and were therefore eliminated in the selection of studies (5, 9, 
12, 25). 
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Types of coconut fat 
 
Studies have shown both positive and negative effects on blood cholesterol levels from an 
intake of VCO. In a study where VCO was compared with regular coconuts fat on rats, 
beneficial results on cholesterol were seen from an intake of VCO. The reason for this was 
explained to be because of the biologically active polyphenol components present in the 
fat(10). In addition to this, another previously published systematic review within the subject of 
coconut fat has also discussed polyphenol components having a possible beneficial role in 
positively altered cholesterol levels(11). Contradictory to this, a study as recent as 2010 
presented results where decreased HDL levels were seen from a diet based on VCO. It should 
be mentioned that this study was judged to have a high risk of bias(1). The data can be 
interpreted as being vague and not consistent enough for a definite conclusion to be drawn 
surrounding VCO.  
 
In media today, when portraying the beneficial aspects of coconut fat, it is often the VCO type 
that is referred to. Due to this fact, findings reached in this systematic review are not 
completely applicable to what is said specifically about VCO. However, the final results of this 
systematic review can be connected to what is said about coconut fat in general. Future large 
scale and widespread interventions are encouraged, as coconut fat is a current topic within the 
world of nutrition. Investigating possible beneficial effects of VCO on humans and differences 
between regular and virgin coconut fat is desirable.  
 
Conclusion 
 
It can be concluded that coconut fat as the main fat in the diet led to significantly higher TC 
levels (+++) and LDL levels (+++) in adults compared to diets rich in HUFA, which is today 
not considered to be beneficial when it comes to blood cholesterol in relation to health. 
Regarding HDL, only one study shows significantly higher levels in all its subjects after a 
coconut fat diet compared to a HUFA based diet (+++), i.e. a beneficial effect. The LDL/HDL 
ratio (++), solely investigated in women, is higher when comparing two SFA diets based 
mainly on coconut fat with a HUFA diet, but only significantly higher comparing LFSA with 
HUFA. The aim is to have a ratio as low as possible.  
 
It is of relevance to mention that the results show that TC and LDL levels are significantly 
higher on a butter diet compared to a coconut fat diet (SFA versus SFA). These levels are 
significantly lower on a HUFA diet compared to a coconut fat diet (HUFA versus SFA). The 
results show short-term effects on blood cholesterol levels as the intervention diets only lasted 
from three to eight weeks. Further research is encouraged for more specific results to be drawn 
surrounding the subject of coconut fats effects on blood cholesterol levels in humans.  
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Appendix 4. Tables showing blood lipid levels in selected studies 
 
 
 
Study 1: Cox et al. 1995  
Effects of coconut oil, butter, and safflower oil on lipids and lipoproteins in persons with 
moderately elevated cholesterol levels 
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Study 2: Mendis et al. 1990  
The effect of daily consumption of coconut fat and soya-bean fat on plasma lipids and 
lipoproteins of young normolipidaemic men 
 
 
 
 
 
 
Study 3: Müller et al. 2003  
The serum LDL/HDL cholesterol ratio is influenced more favourably by exchanging saturated 
with unsaturated fat than by reducing saturated fat in the diet of women 
 
 
